Phase I package adds formulary accountability, recruitment, lab, and EDC features
Phase I package adds formulary accountability, recruitment, lab, and EDC features
LabPas CT 2.5
Green Mountain Logic (Montpellier, VT) has added formulary accountability, recruitment, clinical lab, and EDC components to LabPas CT, its software package designed for Phase I management. LabPas CT 2.5 deploys PDAs on clinic floors for scanning patient and collection vessel barcodes and RFIDs to eliminate error potential. It provides real-time electronic data entry for collection times, comments, dosing, vital signs, and adverse events, and can adapt to changing protocols.
Enhancements in the latest version of LabPas CT allow users to track and manage the entire fomulary chain including accountability, distribution, reconciliation, returns, and destruction. The package also allows users to manage subject information such as biometrics, and handles scheduling and study assignment tasks. Also, the new clinical lab component of LabPas CT integrates clinical trial results into the study database, and the software exports clinical study data in a variety of formats for easy eCRF creation.
Green Mountain Logic, (866) LABPAS1, www.labpas.com
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Full Phase IIIb BATURA Trial Results Show Airsupra Cuts Severe Exacerbations by 47% in Mild Asthma
May 20th 2025Results from the pivotal BATURA trial show that Airsupra (albuterol/budesonide) significantly outperformed albuterol monotherapy in reducing severe asthma exacerbations and systemic corticosteroid exposure, reinforcing its role as a next-generation, anti-inflammatory rescue therapy for mild asthma patients.